147 related articles for article (PubMed ID: 29481776)
1. Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer.
Kozar N; Kruusmaa K; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Arko D; Takač I
Clin Chim Acta; 2018 Jun; 481():108-114. PubMed ID: 29481776
[TBL] [Abstract][Full Text] [Related]
2. Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.
Zeleznik OA; Clish CB; Kraft P; Avila-Pacheco J; Eliassen AH; Tworoger SS
J Natl Cancer Inst; 2020 Jun; 112(6):628-636. PubMed ID: 31593240
[TBL] [Abstract][Full Text] [Related]
3. Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry.
Zhang T; Wu X; Yin M; Fan L; Zhang H; Zhao F; Zhang W; Ke C; Zhang G; Hou Y; Zhou X; Lou G; Li K
Clin Chim Acta; 2012 May; 413(9-10):861-8. PubMed ID: 22309680
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.
Kozar N; Kruusmaa K; Dovnik A; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Takač I; Arko D
Adv Med Sci; 2021 Mar; 66(1):46-51. PubMed ID: 33360772
[TBL] [Abstract][Full Text] [Related]
5. Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling.
Zhang H; Ge T; Cui X; Hou Y; Ke C; Yang M; Yang K; Wang J; Guo B; Zhang F; Lou G; Li K
Mol Biosyst; 2015 Feb; 11(2):516-21. PubMed ID: 25424060
[TBL] [Abstract][Full Text] [Related]
6. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
7. Selection of small plasma peptides for the auxiliary diagnosis and prognosis of epithelial ovarian cancer by using UPLC/MS-based nontargeted and targeted analyses.
Lu X; Li Y; Xia B; Bai Y; Zhang K; Zhang X; Xie H; Sun F; Hou Y; Li K
Int J Cancer; 2019 Apr; 144(8):2033-2042. PubMed ID: 30114318
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic serum profiling detects early-stage high-grade serous ovarian cancer in a mouse model.
Jones CM; Monge ME; Kim J; Matzuk MM; Fernández FM
J Proteome Res; 2015 Feb; 14(2):917-27. PubMed ID: 25567202
[TBL] [Abstract][Full Text] [Related]
9. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
10. Data on metabolomic profiling of ovarian cancer patients' serum for potential diagnostic biomarkers.
Kozar N; Kruusmaa K; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Arko D; Takač I
Data Brief; 2018 Jun; 18():1825-1831. PubMed ID: 29904684
[TBL] [Abstract][Full Text] [Related]
11. Identification of Potential Biomarkers and Metabolic Profiling of Serum in Ovarian Cancer Patients Using UPLC/Q-TOF MS.
Yang W; Mu T; Jiang J; Sun Q; Hou X; Sun Y; Zhong L; Wang C; Sun C
Cell Physiol Biochem; 2018; 51(3):1134-1148. PubMed ID: 30476914
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling.
Zhang T; Wu X; Ke C; Yin M; Li Z; Fan L; Zhang W; Zhang H; Zhao F; Zhou X; Lou G; Li K
J Proteome Res; 2013 Jan; 12(1):505-12. PubMed ID: 23163809
[TBL] [Abstract][Full Text] [Related]
13. Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS.
Shao X; Wang K; Liu X; Gu C; Zhang P; Xie J; Liu W; Sun L; Chen T; Li Y
Clin Chim Acta; 2016 Dec; 463():200-206. PubMed ID: 27784637
[TBL] [Abstract][Full Text] [Related]
14. Targeted metabolomic profiling of low and high grade serous epithelial ovarian cancer tissues: a pilot study.
Garg G; Yilmaz A; Kumar P; Turkoglu O; Mutch DG; Powell MA; Rosen B; Bahado-Singh RO; Graham SF
Metabolomics; 2018 Nov; 14(12):154. PubMed ID: 30830441
[TBL] [Abstract][Full Text] [Related]
15. Lipidomic profiling of human serum enables detection of pancreatic cancer.
Wolrab D; Jirásko R; Cífková E; Höring M; Mei D; Chocholoušková M; Peterka O; Idkowiak J; Hrnčiarová T; Kuchař L; Ahrends R; Brumarová R; Friedecký D; Vivo-Truyols G; Škrha P; Škrha J; Kučera R; Melichar B; Liebisch G; Burkhardt R; Wenk MR; Cazenave-Gassiot A; Karásek P; Novotný I; Greplová K; Hrstka R; Holčapek M
Nat Commun; 2022 Jan; 13(1):124. PubMed ID: 35013261
[TBL] [Abstract][Full Text] [Related]
16. Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery.
Zhang F; Zhang Y; Ke C; Li A; Wang W; Yang K; Liu H; Xie H; Deng K; Zhao W; Yang C; Lou G; Hou Y; Li K
Metabolomics; 2018 Apr; 14(5):65. PubMed ID: 30830339
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.
Mielke MM; Haughey NJ; Han D; An Y; Bandaru VVR; Lyketsos CG; Ferrucci L; Resnick SM
J Alzheimers Dis; 2017; 60(3):819-828. PubMed ID: 28035934
[TBL] [Abstract][Full Text] [Related]
18. The ascites N-glycome of epithelial ovarian cancer patients.
Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
[TBL] [Abstract][Full Text] [Related]
19. Highly-accurate metabolomic detection of early-stage ovarian cancer.
Gaul DA; Mezencev R; Long TQ; Jones CM; Benigno BB; Gray A; Fernández FM; McDonald JF
Sci Rep; 2015 Nov; 5():16351. PubMed ID: 26573008
[TBL] [Abstract][Full Text] [Related]
20. Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer.
Hishinuma E; Shimada M; Matsukawa N; Saigusa D; Li B; Kudo K; Tsuji K; Shigeta S; Tokunaga H; Kumada K; Komine K; Shirota H; Aoki Y; Motoike IN; Yasuda J; Kinoshita K; Yamamoto M; Koshiba S; Yaegashi N
Toxins (Basel); 2021 Jun; 13(7):. PubMed ID: 34209281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
